ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers From ACTR Meeting

October 22, 1976

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Daily Aspirin May Reduce Risk By 20 Percent, Study Says

February 28, 2014

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

November 27, 2009